Table 3.
Interventions | NT-proBNP | LVEF | LVEDD | LVESD | LVESD | MLHFQ | 6WMT | Effective | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Interventions1 | Interventions2 | Effect size | 95%CI | Effect size | 95%CI | Effect size | 95%CI | Effect size | 95%CI | Effect size | 95%CI | Effect size | 95%CI | Effect size | 95%CI | Effect size | 95%CI |
C + D | A + C + D | −74.97 | −142.08, −7.86 | 22.1 | 10.46, 46.71 | 0.24 | 1.88, 4.31 | 2.21 | −0.36, 4.78 | 22.7 | 16.94, 28.47 | −1.1 | −9.13, 6.93 | 22.71 | 16.94, 28.47 | 18.54 | 32.47.4.61 |
B + C + D | 17 | −126.93, 126.57 | 5.75 | 0.00, 516.25 | 5.75 | −2.34, 5.84 | - | - | 0.55 | −13.06, 14.16 | 3.32 | −8.88, 15.52 | 0.55 | −13.06, 14.16 | 19.09 | 13.90, 23.12 | |
D | 15.98 | −109.38, 141.34 | 0.24 | 0.02, 2.62 | 0.1 | −2.44, 5.26 | - | - | −18.53 | −32.47, −4.61 | −2.47 | −11.02, 6.08 | −18.54 | −32.47, −4.61 | 0.45 | 12.65, 23.32 | |
D | A + D | 90.95 | −51.24, 233.15 | 4.1 | 0.06, 266.59 | - | - | - | - | −26.39 | −80.40, 27.61 | −5.25 | 8.63, −1.86 | 45.49 | 23.59, 67.39 | 12.34 | 34.27, 12.45 |
B + D | 16.16 | −162.11, 194.43 | 2692.8 | 28.34, 255.86 | - | - | 3.47 | −4.05, 11.00 | −18.55 | −77.02, 39.92 | −7.44 | −13.07, −1.80 | 87.64 | 6.31, 68.97 | 10.10 | 23.29.45.0 | |
A + C + D | B + C + D | 74.795 | −68.63, 218.21 | 0.26 | 0.02, 3.60 | 2.4 | 0.20, 28.59 | - | - | −22.15 | −36.94, −7.37 | 4.42 | −13.55, 22.39 | −22.16 | −36.94, −7.37 | 12.23 | 22.23, 29.01 |
LVEDD = left ventricular end-diastolic internal diameter, LVESD = left ventricular end-systolic internal diameter, LVEF = left ventricular ejection fraction, MLHFQ = Minnesota Living with Heart Failure Questionnaire, NT-proBNP = N-terminal brain natriuretic peptidogen.